Drug treatment of hypertension.
D018663:Adrenergic Agents / Q000009:adverse effects / Q000627:therapeutic use; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000494:pharmacology; D001581:Benzothiadiazines; D002490:Central Nervous System / Q000187:drug effects; D003000:Clonidine / Q000627:therapeutic use; D004232:Diuretics; D005730:Ganglionic Blockers / Q000627:therapeutic use; D006801:Humans; D006830:Hydralazine / Q000009:adverse effects; D006973:Hypertension / Q000188:drug therapy*; D009599:Nitroprusside / Q000627:therapeutic use; D012083:Renin / Q000097:blood; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use
D018663:Adrenergic Agents; D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D001581:Benzothiadiazines; D004232:Diuretics; D005730:Ganglionic Blockers; D049993:Sodium Chloride Symporter Inhibitors; D009599:Nitroprusside; D006830:Hydralazine; D012083:Renin; D003000:Clonidine